Mizuho senior analyst Graig Suvannavejh joins BiotechTV for Analyst Thursdays from Kendall Square

Vedanta Biosciences founder and CEO Bernat Olle shares an expert take on microbiome drug development

Biotech lab technologies expert Bob Gantzer talks about the digital lab book, rovers, and future technologies still to come in biotech

Innovation Day San Diego: The director of UCSD's Center for RNA Technologies and Therapeutics shares his thoughts on the RNA field

Houston Oncology Summit: The Cancer Focus Fund is closing on its second fund - it's a unique model that helps companies with knowhow and trial support at MD Anderson

Houston Oncology Summit: MD Anderson's Chief Data & Analytics Officer describes the impact of the digitization of medicine

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Houston Oncology Summit: MD Anderson Professor of Immunology Michael Curran talks turning cold tumors hot, including work by his company ImmunoGenesis

Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference

Houston Oncology Summit: MD Anderson's Katy Rezvani, an expert in NK cell therapies, gives an overview of what is in development in this space

Houston Oncology Summit: MD Anderson's John Heymach, a leading expert in lung cancer, talks about the latest in TKI's, KRAS, Bi-specifics, and more

Houston Oncology Summit: MD Anderson's Ferran Prat describes how companies can partner with MD Anderson and what technologies excite him

Lars Lannfelt, inventor of the approved (in the U.S. and elsewhere) Alzheimer's medicine Leqembi, describes how the drug works and shares his understanding of Alzheimer's disease

The CEO of Life Sciences PA introduces us to the Life Sciences Future meeting and shares his take on the health of the sector

Pareto Securities' biotech analyst Dan Akschuti gives an overview of the 15th Annual Healthcare Conference and highlights companies in the region

Biotech industry veteran Pascal Besman shares advice for European companies on how to best present yourself to U.S. investors

William Blair analyst Matt Phipps reviews key #ESMO24 data from his coverage list

From Biocom California Women's Health Conference: Crescent Ridge Managing Partner Maria Gonzalez-Blanch talks about investing in women's health

Previewing the 2024 ESMO Congress with oncology watcher Bertrand Delsuc

HSBC's Rajesh Kumar joins BiotechTV for Analyst Thursdays and talks PD-1xVEGF, obesity, European conglomerates, and more